A real-life observational study in severe eosinophilic asthma adult participant treated with benralizumab in Italy

Trial Identifier: D3250R00141
Sponsor: AstraZeneca
Start Date: December 2025
Primary Completion Date: December 2028
Study Completion Date: December 2028

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
italy, Bari Bari, italy, 70120
italy, Brescia Brescia, italy, 25123
italy, Catanzaro Catanzaro, italy, 88100
italy, Salerno Battipaglia, Salerno, italy, 84031
Italy, Bergamo Bergamo, Italy, 24127
Italy, Bologna Bologna, Italy, 40138
Italy, Bologna Bologna, Italy, 40139
Italy, Catania Catania, Italy, 95123
Italy, Firenze Firenze, Italy, 50134
Italy, Foggia Foggia, Italy, 71122
Italy, Messina Messina, Italy, 98124
Italy, Milano Milano, Italy, 20142
Italy, Modena modena, Modena, Italy, 41125
Italy, Napoli Napoli, Italy, 80131
Italy, Padova Cittadella, Padova, Italy, 35013
Italy, Padova Padova, Italy, 35128
Italy, Palermo Palermo, Italy, 90127
Italy, Pavia Pavia, Italy, 27100
Italy, Roma Roma, Italy, 00189
Italy, Roma Roma, Italy, 00152
Italy, Sassari Sassari, Italy, 07100
Italy, Siena Siena, Italy, 53100
Italy, Teramo Giulianova, Teramo, Italy, 64021
Italy, Torino Torino, Italy, 10128
Italy, Treviso Montebelluna, Treviso, Italy, 31044
Italy, Varese Tradate, Varese, Italy, 21049
Italy, Verona Verona, Italy, 37134